In this edition of our newsletter we focus on Pulmonology.

Please review some of the latest develpments and have a look at our selection of  industry news.

• Respiratory Syncytial Virus (RSV) on target for drug development
• The impact of Duchenne Muscolar Dystrophy on pulmonary function
• Cystic Fibrosis treatment: the globalization of drug development and the role of the European Medicines Agency

check out our newsletter +

For more information about our clinical development expertise and services, please get in touch with us.